Gregory Scott is a National Institute for Health Research (NIHR) funded Neurology Academic Clinical Lecturer (ACL) and Neurology Specialty Trainee (Registrar).
His research is motivated by clinically important questions about consciousness, and its relationship to brain injury, complexity and criticality. His research has used functional MRI, diffusion tensor imaging, positron emission tomography, electroencephalography, computational simulations and voltage indicator imaging.
Dr Scott has a PhD (GSK-Wellcome Trust funded) from Imperial College London. He also has an MBBS (Medicine), MSc (Advanced Computing) and BEng (Computing), all from Imperial.
In his PhD (https://bit.ly/2sjcuYF), he used PET, MRI and plasma markers to characterise the relationship between brain inflammation and white matter damage following traumatic brain injury, and to investigate the action of the drug minocycline on chronic neuroinflammation.
et al., [(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis., Journal of Nuclear Medicine, ISSN:1535-5667
et al., 2018, Spatial patterns of progressive brain volume loss after moderate-severe traumatic brain injury, Brain, Vol:141, ISSN:0006-8950, Pages:822-836
et al., 2018, Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration, Brain, Vol:141, ISSN:0006-8950, Pages:459-471
et al., 2017, Microglial Activation in Traumatic Brain Injury, Frontiers in Aging Neuroscience, Vol:9, ISSN:1663-4365
et al., 2016, Seeds of neuroendocrine doubt, Nature, Vol:535, ISSN:0028-0836, Pages:E1-E2